Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles

Journal of Virological Methods

Volumn 127, Issue 1, 2005, Pages 40-45

  Rohr, Ulrich Peter ^a   Heyd, Florian ^a   Neukirchen, Judith ^a   Wulf, Marc Andre ^a   Queitsch, Iris ^b   Kroener Lux, Gabriele ^b   Steidl, Ulrich ^a   Fenk, Roland ^a   Haas, Rainer ^a   Kronenwett, Ralf ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Progen Biotechnik GmbH   (Germany)

Author keywords

Infectious assay; qPCR; rAAV 2

Indexed keywords

DOUBLE STRANDED DNA; PARVOVIRUS VECTOR; SINGLE STRANDED DNA; VIRUS DNA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGESTION; DNA VIRUS; ENZYME SPECIFICITY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENOME; HELA CELL; HOST CELL; HUMAN; HUMAN CELL; LIFE CYCLE; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VALIDATION PROCESS; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS TITRATION;

ASPERGILLUS NUCLEASE S1; CELL LINE; DEPENDOVIRUS; DNA, SINGLE-STRANDED; DNA, VIRAL; GENETIC VECTORS; HUMANS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS 2;

EID: 21044435643     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2005.03.006     Document Type: Article

References (27)

1. E.M. Atkinson, D.J. Debelak, L.A. Hart, and T.C. Reynolds A high-throughput hybridization method for titer determination of viruses and gene therapy vectors Nucl. Acids Res. 26 1998 2821 2823
2. L. Cao, Y. Liu, M.J. During, and W. Xiao High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids J. Virol. 74 2000 11456 11463
3. G. Chadeuf, D. Favre, J. Tessier, N. Provost, P. Nony, J. Kleinschmidt, P. Moullier, and A. Salvetti Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome J. Gene Med. 2 2000 260 268
4. L. Drittanti, C. Rivet, P. Manceau, O. Danos, and M. Vega High throughput production, screening and analysis of adeno-associated viral vectors Gene Ther. 7 2000 924 929
5. D. Duan, P. Sharma, L. Dudus, Y. Zhang, S. Sanlioglu, Z. Yan, Y. Yue, Y. Ye, R. Lester, J. Yang, K.J. Fisher, and J.F. Engelhardt Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression J. Virol. 73 1999 161 166
6. D. Duan, Y. Yue, Z. Yan, J. Yang, and J.F. Engelhardt Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus J. Clin. Invest. 105 2000 1573 1587
7. F.K. Ferrari, T. Samulski, T. Shenk, and R.J. Samulski Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors J. Virol. 70 1996 3227 3234
8. K.J. Fisher, G.P. Gao, M.D. Weitzman, R. DeMatteo, J.F. Burda, and J.M. Wilson Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis J. Virol. 70 1996 520 532
9. T.R. Flotte, R. Solow, R.A. Owens, S. Afione, P.L. Zeitlin, and B.J. Carter Gene expression from adeno-associated virus vectors in airway epithelial cells Am. J. Respir. Cell. Mol. Biol. 7 1992 349 356
10. D. Grimm, A. Kern, M. Pawlita, F.K. Ferrari, R.J. Samulski, and J.A. Kleinschmidt Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2 Gene Ther. 6 1999 1322 1330
11. A. Hörster, B. Teichmann, R. Hormes, D. Grimm, J. Kleinschmidt, and G. Sczakiel Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy Gene Ther. 6 1999 1231 1238
12. M.A. Kay, C.S. Manno, M.V. Ragni, P.J. Larson, L.B. Couto, A. McClelland, B. Glader, A.J. Chew, S.J. Tai, R.W. Herzog, V. Arruda, F. Johnson, C. Scallan, E. Skarsgard, A.W. Flake, and K.A. High Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector Nat. Genet. 24 2000 257 261
13. R.B. Moss, D. Rodman, L.T. Spencer, M.L. Aitken, P.L. Zeitlin, D. Waltz, C. Milla, A.S. Brody, J.P. Clancy, B. Ramsey, N. Hamblett, and A.E. Heald Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial Chest 125 2004 509 521
14. H. Nakai, T.A. Storm, and M.A. Kay Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo J. Virol. 74 2000 9451 9463
15. U. Rohr, M. Wulf, S. Stahn, U. Steidl, R. Haas, and R. Kronenwett Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR J. Virol. Methods 106 2002 81 89
16. U. Rohr, R. Kronenwett, D. Grimm, J. Kleinschmidt, and R. Haas Primary human cells differ in their susceptibility to rAAV-2-mediated gene transfer and duration of reporter gene expression J. Virol. Methods 105 2002 265 275
17. U. Rohr, M. Wulf, S. Stahn, F. Heyd, U. Steidl, R. Fenk, B. Opalka, G. Pitschke, H. Prisack, H. Bojar, R. Haas, and R. Kronenwett Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector Cancer Gene Ther. 10 2003 898 906
18. M. Ruffing, H. Zentgraf, and J.A. Kleinschmidt Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells J. Virol. 66 1992 6922 6930
19. A. Salvetti, S. Orève, G. Chadeuf, D. Favre, Y. Cherel, P. Champion-Arnaud, J. David-Ameline, and P. Moullier Factors influencing recombinant adeno-associated virus production Hum. Gene Ther. 9 1998 695 706
20. S. Sanlioglu, P.K. Benson, J. Yang, E.M. Atkinson, T. Reynolds, and J.F. Engelhardt Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by Rac1 and Phosphatidylinositol-3 kinase activation J. Virol. 74 2000 9184 9196
21. G. Seisenberger, M.U. Ried, T. Endreß, H. Büning, M. Hallek, and C. Bräuchle Real-time single-molecule imaging of the infection pathway of an adeno-associated virus Science 294 2001 1929 1932
22. C. Summerford, J.S. Bartlett, and R.J. Samulski αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection Nat. Med. 5 1999 78 82
23. C. Summerford, and R.J. Samulski Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions J. Virol. 72 1998 1438 1445
24. M.R. Veldvijk, J. Topaly, S. Laufs, U.R. Hengge, F. Wenz, W.J. Zeller, and S. Fruehauf Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks Mol. Ther. 6 2002 272 278
25. N. Vincent-Lacaze, R.O. Snyder, R. Gluzman, D. Bohl, C. Lagarde, and O. Danos Structure of adeno-associated virus vector DNA following transduction of skeletal muscle J. Virol. 73 1999 1949 1955
26. J.A. Wagner, T. Reynolds, M.L. Moran, R.B. Moss, J.J. Wine, T.R. Flotte, and P. Gardner Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus Lancet 351 1998 1702 1703
27. S. Zolotukhin, B.J. Byrne, E. Mason, I. Zolotukhin, M. Potter, K. Chesnut, C. Summerford, R.J. Samulski, and N. Muzyczka Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield Gene Ther. 6 1999 973 985